Market Indices
Latest News
 |
Key Points- Robbins Geller Rudman & Dowd LLP announces lead plaintiff...August 12, 2026 CAPR 6.62% |
| ||
| ||
| ||
|
Price Targets
from UBS issued a price target of $8.00 for LVO on 2026-08-12 20:01:48.The adjusted price target was set to $8.00.At the time of the announcement, LVO was...
August 12, 2026 LVO -11.62%
Kevin Steinke from Barrington issued a price target of $19.00 for HQI on 2026-08-12 18:59:18.The adjusted price target was set to $19.00.At the time of the announcement, HQI...
August 12, 2026 HQI -3.20%
Neil Young from Needham issued a price target of $20.00 for QUIK on 2026-08-12 13:02:04.The adjusted price target was set to $20.00.At the time of the announcement, QUIK...
August 12, 2026 QUIK -8.08%
Ryan Deschner from Raymond James issued a price target of $18.00 for ACHV on 2026-08-12 12:37:25.The adjusted price target was set to $18.00.At the time of the announcement,
August 12, 2026 ACHV -1.18%
Daniel Arias from Stifel Nicolaus issued a price target of $12.00 for MASS on 2026-08-12 12:22:00.The adjusted price target was set to $12.00.At the time of the announcement,
August 12, 2026 MASS 0.10%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| EGRX Eagle Pharmaceuticals, In | 0.60
764.20% | ||||||||||||||||||
| CANG Cango Inc. | 2.19
27.33% | ||||||||||||||||||
| IPHA Innate Pharma S.A. | 2.47
14.88% | ||||||||||||||||||
| NOTE FiscalNote Holdings, Inc. | 0.08
14.26% | ||||||||||||||||||
| BTAI BioXcel Therapeutics, Inc | 1.06
13.75% | ||||||||||||||||||
| IZM ICZOOM Group Inc. | 0.30
12.78% | ||||||||||||||||||
| PYXS Pyxis Oncology, Inc. | 3.18
12.37% | ||||||||||||||||||
| LINK Interlink Electronics, In | 5.69
11.57% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 2.66%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -2.33%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE 0.00%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK 0.03%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 1.84%